F071 HIV and STIs: Hot Topics
DESCRIPTION
Sexually transmitted infection rates have been rapidly increasing in the post-pandemic world. Patients frequently present to their dermatologist for evaluation and management of their STIs. The nature of infectious diseases is that the epidemiology and treatment options are always changing. This session will update the clinicians with the latest trends in STIs like HIV, HSV, Kaposi's sarcoma and syphilis and guide them in appropriate lab testing and best and newest treatment options for their patients.
LEARNING OBJECTIVES
Recognize the changing epidemiology of sexually transmitted infections that affect the skin.
Order appropriate lab evaluations for patients with STIs.
Select the most appropriate treatment for patients with STIs that affect the skin.
SCHEDULE
9:00 AM
Guilty by Association: Skin Conditions That Mimic STIs
Philip R. Doiron, MD, FAAD
9:30 AM
Syphilis: What’s New with this Old Disease?
10:00 AM
Kaposi Sarcoma in the Modern Era: What Dermatologists Need to Know
Kieron S. Leslie, MBBS
10:30 AM
Care for people with HSV
Anna Wald, MD
DIRECTOR
Kieron S. Leslie, MBBS
University of California, San Francisco
SPEAKERS
Philip R. Doiron, MD, FAAD
University of Toronto
Anna Wald, MD
DISCLOSURES
Philip R. Doiron, MD, FAAD
AbbVie – Advisory Board(Honoraria); Amgen – Advisory Board(Honoraria); Arcutis, Inc. – Advisory Board(Honoraria); Eli Lilly – Advisory Board(Honoraria); Galderma – Advisory Board(Honoraria); Incyte – Advisory Board(Honoraria); Janssen Pharmaceuticals, Inc – Advisory Board(Honoraria); Leo Pharma – Advisory Board(Honoraria); Organon – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria); UCB – Advisory Board(Honoraria);
Kieron S. Leslie, MBBS
No financial relationships exist with ineligible companies.
Anna Wald, MD
Agenus Inc. – Investigator(Grants/Research Funding); AiCuris GmbH & Co. KG – Consultant(Honoraria); Genocea Biosciences – Investigator(Grants/Research Funding); Gilead Sciences, Inc – Investigator(Grants/Research Funding);